Dolby Laboratories (NYSE:DLB) CEO Kevin Yeaman Sells 26,766 Shares of Stock

Dolby Laboratories (NYSE:DLB) CEO Kevin Yeaman sold 26,766 shares of the firm’s stock in a transaction that occurred on Tuesday, December 16th. The stock was sold at an average price of $66.74, for a total transaction of $1,786,362.84. Following the transaction, the chief executive officer owned 105,128 shares in the company, valued at approximately $7,016,242.72. This trade represents a 20.29% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

Dolby Laboratories Price Performance

Shares of NYSE:DLB opened at $67.09 on Thursday. Dolby Laboratories has a 1-year low of $64.02 and a 1-year high of $89.66. The stock has a market cap of $6.41 billion, a P/E ratio of 25.51 and a beta of 0.89. The firm has a fifty day moving average price of $66.88 and a 200 day moving average price of $71.25.

Dolby Laboratories (NYSE:DLB) last announced its earnings results on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, beating analysts’ consensus estimates of $0.70 by $0.29. Dolby Laboratories had a net margin of 18.90% and a return on equity of 11.99%. The business had revenue of $307.02 million during the quarter, compared to analysts’ expectations of $305.76 million. During the same period in the prior year, the company earned $0.61 earnings per share. The business’s revenue was up .7% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. Sell-side analysts expect that Dolby Laboratories will post 2.94 EPS for the current fiscal year.

Dolby Laboratories Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd were issued a $0.36 dividend. The ex-dividend date of this dividend was Tuesday, December 2nd. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.33. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.1%. Dolby Laboratories’s dividend payout ratio is presently 54.75%.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on DLB. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Monday. Rosenblatt Securities dropped their price target on shares of Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating on the stock in a research note on Wednesday, November 19th. Wall Street Zen downgraded shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. Baird R W raised Dolby Laboratories to a “hold” rating in a report on Friday, September 5th. Finally, Barrington Research cut their target price on Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating for the company in a research note on Wednesday, November 19th. Three equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $92.00.

Institutional Investors Weigh In On Dolby Laboratories

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Boothbay Fund Management LLC lifted its position in Dolby Laboratories by 4.1% in the second quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock worth $299,000 after purchasing an additional 157 shares during the period. MAI Capital Management raised its stake in shares of Dolby Laboratories by 87.1% in the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock worth $28,000 after buying an additional 162 shares in the last quarter. Mitchell & Pahl Private Wealth LLC lifted its holdings in shares of Dolby Laboratories by 1.1% in the third quarter. Mitchell & Pahl Private Wealth LLC now owns 15,733 shares of the electronics maker’s stock valued at $1,139,000 after buying an additional 170 shares during the period. Equitable Trust Co. boosted its stake in Dolby Laboratories by 3.3% during the second quarter. Equitable Trust Co. now owns 5,567 shares of the electronics maker’s stock valued at $413,000 after buying an additional 177 shares in the last quarter. Finally, Steward Partners Investment Advisory LLC grew its holdings in Dolby Laboratories by 13.9% during the second quarter. Steward Partners Investment Advisory LLC now owns 1,587 shares of the electronics maker’s stock worth $118,000 after acquiring an additional 194 shares during the period. 58.56% of the stock is currently owned by institutional investors and hedge funds.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.